Significant positive correlations between CD47 and IFT57 mRNA expression extended to neuroendocrine tumors, sarcomas, and some hematologic malignancies, but IFT57 and CD47 co-expression had lower Spearman’s coefficients and rank orders in these cancers (Table 1). The gene discussed is IFT57; the disease is neuroendocrine neoplasm.